Stocks and Investing Stocks and Investing
Mon, September 23, 2024

Eun Yang Maintained (UTHR) at Strong Buy with Increased Target to $432 on, Sep 23rd, 2024


Published on 2024-10-28 14:24:30 - WOPRAI, Eun Yang
  Print publication without navigation


Eun Yang of Jefferies, Maintained "United Therapeutics Corporation" (UTHR) at Strong Buy with Increased Target from $315 to $432 on, Sep 23rd, 2024.

Eun has made no other calls on UTHR in the last 4 months.



There are 7 other peers that have a rating on UTHR. Out of the 7 peers that are also analyzing UTHR, 1 agrees with Eun's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Terence Flynn of "Morgan Stanley" Downgraded from Buy to Hold and Increased Target to $321 on, Thursday, July 11th, 2024


These are the ratings of the 6 analyists that currently disagree with Eun


  • Hartaj Singh of "Oppenheimer" Maintained at Buy with Increased Target to $575 on, Wednesday, August 28th, 2024
  • Tiago Fauth of "Wells Fargo" Maintained at Buy with Increased Target to $380 on, Tuesday, August 20th, 2024
  • Greg Harrison of "B of A Securities" Maintained at Sell with Decreased Target to $280 on, Thursday, August 1st, 2024
  • Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $400 on, Thursday, August 1st, 2024
  • Joseph Thome of "TD Cowen" Maintained at Strong Buy with Increased Target to $350 on, Thursday, July 11th, 2024
  • Ashwani Verma of "UBS" Maintained at Strong Buy with Increased Target to $370 on, Monday, July 8th, 2024
Contributing Sources